Skip navigation and go directly to contentRFPK logo Return to Main.Resource Facility for Population Kinetics
main : publications

What's New?

Research and Development

Service

Collaborations

Team RFPK

Publications

Training

About RFPK

Contact Us

Members Only

Search

2004 Publications

Make a selection to see details:

All links listed below will open in a new window. Close the new window to return to this page.

Papers

[top of page]

Books and book chapters

  • Sparacino G, Pillonetto G, De Nicolao G, Cobelli C. Deconvoluzione per l'analisi di segnali fisiologici. In: "Metodi Avanzati di Elaborazione di Segnali Biomedici", S.Cerutti and C.Marchesi, Eds., Patron Editore, Bologna, Italy, 163-188, 2004.

Abstracts

  • Barrett PH. HDL metabolism: a model of LpAI:AII kinetics. 34th KinMet 2004 - Satellite Symposium on Kinetics and Kinetic Modeling of Lipoprotein, Lipid, and Sterol Metabolism in Systems Ranging from Human Subjects to Cultured Cells, May 5, 2004, San Francisco, CA. (http://www.bioinformaticsservices.com/kinmet2004.html)
  • Barrett PH. Modeling of Human Apolipoprotein A-I and B Metabolism (Berman-Zech Award Lecture). 34th KinMet 2004 - Satellite Symposium on Kinetics and Kinetic Modeling of Lipoprotein, Lipid, and Sterol Metabolism in Systems Ranging from Human Subjects to Cultured Cells, May 5, 2004, San Francisco, CA.(http://www.bioinformaticsservices.com/kinmet2004.html)
  • Barrett PHR, Ji J, Johnson AG, Serone A, Loehrer F, Watts GF. Fenofibrate increases HDL LpAI:AII production in men with the metabolic syndrome. Atherosclerosis Suppl 2004; 5: 47.
  • Barrett PHR, Farvid MS, Zilko SR, Allen MC, Chan DC, Watts GF. HDL apolipoprotein A-I kinetics in the metabolic syndrome: Pooled analysis of stable isotope studies. Atherosclerosis Suppl 2004; 5: 48.
  • Barrett PHR. Lipoprotein kinetics in the metabolic syndrome. XV International Symposium on Drugs affecting Lipid Metabolism, Venice, October 2004.
    (http://www.lorenzinifoundation.org/dalm2004/pag1-20.pdf)
  • Barrett PHR, Ji J, Johnson AG, Serone A, Loehrer F, Watts GF. Fenofibrate increases HDL LpAI:AII production in men with the metabolic syndrome. Arterio Thromb Vasc Biol 2004; 24: e79.
  • Basu A, Dalla Man C, Toffolo G, Basu R, Cobelli C, Rizza RA. Effect of Type 2 Diabetes on Meal Tolerance and Insulin Secretion. Diabetes 53 (Supplement 2): A579:2445-P, 2004.
  • Basu R, Singh RJ, Chittilpilly EG, Johson MC, Toffolo G, Cobelli C, Rizza R. Splanchnic cortisol production occurs in humans: evidence for tissue specific 11-B hydroxyl steroid dehydrogenase type 1 activity. Diabetologia 47, Suppl.1, A597, 2004.
  • Baumann EE, Dalla Man C, Cobelli C, Rosenfield RL. Insulin Sensitivity (Si) by OGTT Minimal Model Assessment Is Low in Hyperandrogenic Children. Diabetes 53 (Supplement 2): A306:1263-P, 2004.
  • Bertoldo A., Price J, Mathis C, Mason S, Holt D, Kelley C,  McKolanis T, Cobelli C, Kelley DE. Glucose transport in human skeletal muscle using dynamic PET imaging of [11C]-3-O-Methyl-D-glucose. 40th Annual Meeting of the European Association for the Study of Diabetes, Munich, Germany, 5 - 9 September 2004.
  • Bertoldo A, Corazza S, Zanderigo F, Pillonetto G, Cosottini M, Cobelli C.Assessment of Regional Cerebral Blood Flow by Bolus-Tracking MRI Images: Characterization of the Tissue Residue Function Using Nonlinear Stochastic Regularization Method. Proceedings of MEDICON 2004 - Mediterranean Conference on Medical and Biological Engineering, Island of Ischia, Naples, Italy, July 31 - August 5 2004.
  • Bolitho P, Chan DC, Barrett PHR, Watts GF. Effect of atorvastatin and fish oil on HDL apolipoprotein A-I kinetics in the metabolic syndrome. Atherosclerosis Suppl 2004; 5: 48.
  • Bovo V, Bertoldo A, Price JC, Frank GK, Kaye WH, Cobelli C. Examination of a Three-Tissue Compartment Model for [11C]WAY-100635: Insight and Comparison with a Two-Tissue Compartment Model. Neuroimage, 22 (Suppl.2): T65, 2004.
  • Campioni M, Toffolo G, Rizza R, Cobelli C. Estimation of hepatic insulin extraction during IM-IVGTT: individual vs. standard kinetic parameters. MEDICON 2004, Mediterranean Conference on Medical and Biological Engineering, Naples, Italy, July 31-August 5, 2004.
  • Campioni M, Toffolo G, Shuster LT, Service FJ, Rizza RA, Cobelli C. Incretin Factors Potentiate Beta-Cell Sensitivity to Glucose as Well as to Its Rate of Change: OGTT and Matched Intravenous Study. Diabetes 53 (Supplement 2): A320:1323-P, 2004.
  • Corazza S, Sparacino G, Maran A, Cobelli C. Prediction method to alert patient hyper/hypo-glycaemic events from continuous glucose monitoring. In: Proceedings of the Diabetes Technology Meeting, October 28-30, 2004, Philadelphia, 2004.
  • Dalla Man C, Basu R, Toffolo G, Rizza RA, Cobelli C. Assessment of Hepatic Insulin Sensitivity and Glucose Effectiveness. Diabetes 53 (Supplement 2): A321:1328-P, 2004.
  • Dalla Man C, Cobelli C,Basu R, Rizza R, Toffolo G. Novel Assessment of Glucose and Insulin Control on Glucose Production During a Meal. Proceedings of MEDICON and HEALTH TELEMATICS 2004 Conference, Naples, Italy, July 31-August 5, 2004.
  • Dalla Man C, Toffolo G, Caumo A, Rizza RA, Polonsky KS, Cobelli C. 120 min - 7 Samples OGTT/MEAL Minimal Model Simultaneous Assessment of Insulin Sensitivity and Beta-Cell Responsivity: Validation Against 300/420 min Protocols. Diabetes 53 (Supplement 2): A321:1327-P, 2004.
  • DiCamillo B, Sanchez-Cabo, Nair SK, Toffolo G, Cobelli C. Identification of Gene Regulatory Modules Using Entropy And Mutual Information. In: Proceedings of MEDICON Mediterranean Conference on Medical and Biological Engineering, Naples, July 31-August 5, 2004.
  • DiCamillo B, Toffolo G, Cobelli C, Nair SK. Selection of Insulin Regulated Gene Expression Profiles Based on Intensity-Dependent Noise Distribution of Microarray Data. In: Proceedings of BITS2004: Bioinformatics Italian Society Meeting, March 26-27 2004, Padova, Italy
  • Dodds MG, Hooker AC, Vicini P. Robust Population Pharmacokinetic Experiment Design. PAGE (Population Approach Group in Europe) Thirteenth Meeting, 17-18 June, 2004, Uppsala, Sweden. (http://www.page-meeting.org/)
  • Dodds MG, Vicini P, Visich JE. A Population PK Model for Recombinant Factor XIII in Healthy Volunteers. PAGE (Population Approach Group in Europe) Thirteenth Meeting, 17-18 June, 2004, Uppsala, Sweden. (http://www.page-meeting.org/)
  • Farvid MS, Ng WK, Chan DC, Barrett PHR, Watts GF. Adiponectin as a determinant of VLDL apoB kinetics in men. Atherosclerosis Suppl 2004; 5: 30.
  • Farvid MS, Ng WK, Chan DC, Barrett PHR, Watts GF. Association between plasma adiponectin levels and adipose tissue compartments in men. Atherosclerosis Suppl 2004; 5: 50.
  • Feng Y, Bies RR, Bobek MB, Kane SL. Population pharmacokinetics analysis of patients receiving enoxaparin by continuous intravenous infusion. Clinical Pharmacology and Therapeutics 75(2): P30, PI-102, 2004.
  • Feng Y, Pollock BG, Reynolds C, Bies RR. Paroxetine pharmacokinetics in geriatric patients. AAPS PharmSci Abstract M1116, 2004.
  • Hooker A, Dodds MG, Vicini P. Evaluating the predictive power of the Fisher information matrix in population optimal experimental design. PAGE (Population Approach Group in Europe) Thirteenth Meeting, 17-18 June, 2004, Uppsala, Sweden. (http://www.page-meeting.org/)
  • Kee P, Rye KA, Moorehouse L, Barrett PHR, Barter PJ. The effects of cholesteryl ester transfer protein (CETP) inhibition on the metabolism of cholesteryl esters in high density lipoproteins: Insights into reverse cholesterol transport. Cardiac Society of Australia and New Zealand Scientific Session, August 4, 2004.
  • Krudys K, Vicini P. Validation of an Integrated Model of Peripheral and Liver Regulation of Glucose Kinetics during the IVGTT. Diabetes 53 (Supplement 2): A373:1555-P, 2004.
  • Lewis LD, Rosner GL, Miller AA, Egorin MJ, Relling H, Kastrissios H, Bies R, Ratain MJ. CALGB9871. The pharmacokinetics and pharmacodynamics of docetaxel (DCTX) in Caucasian and African American patients with solid tumors. ASCO 2004 New Orleans LA
  • Maran A, Sparacino G, Pavanini A, Corazza S, Crepaldi M, Poscia A, Avogaro A, Cobelli C. On-line glucose prediction from continuous monitoring data and prevention of hyper/hypo-glycaemic events, Diabetologia 47, Suppl.1, pag.A317, 2004.
  • Maran A, Sparacino G, Pavanini A, Corazza S, Crepaldi C, Tiengo A, Avogaro A, Cobelli C. Predizione dei valori glicemici mediante monitoraggio in continuo del glucosio. Atti del XX Convegno della Società Italiana di Diabetologia, Roma, 26-29 maggio 2004, 2004.
  • Maran A, Sparacino G, Pavanini A, Crepaldi C, Poscia A, Tiengo A, Avogaro A, Cobelli C. Glucose Prediction from Continuous Subcutaneous Monitoring Data. Diabetes 53 (Supplement 2): A105:445-P, 2004.
  • Moresco RM, Messa C, Tagliavini F, Panzacchi A, Giovagnoli MR, Matarrese M, Pietra L, Bertoldo A, Rizzo G, Giaccone G, Di Fede G, Mattioli C, Cobelli C, Fazio F, Bugiani O. Microglial activation in Creutzfeldt-Jakob disease (CJD): a PET [C-11]PK11195. Neuroimage, 22 (Suppl.2): T86, 2004.
  • Ng WK, Chan DC, Susekov A, Watts GF, Barrett PHR. Chylomicron remnant kinetics in the metabolic syndrome measured with stable isotopy. Atherosclerosis Suppl 2004; 5: 57.
  • Pierce CH, Dills RR, Freidhoff J, Deneen A, La Casse A, Morgan MS.Toxicokinetics of MTBE in Human Subjects. 2004 5th Annual Environmental and Occupational Health conference, July 11-13, 2004, Minneapolis, MN. (http://www.asph.org/document.cfm?page=847)
  • Silber H, Stetina P, McHugh B, Gieschke R, Frey N, Vicini P, Simonsson USH, Karlsson MO. A disease model for the regulation of the glucose-insulin system. Proceedings of PKUK 2004, 17th - 19th November 2004, Belfast, Northern Ireland, UK, p. 32.
  • Silber H, Stetina P, McHugh B, Gieschke R, Frey N, Vicini P, Simonsson USH, Karlsson MO. A disease model for the regulation of the glucose-insulin system. PAGE (Population Approach Group in Europe) Thirteenth Meeting, 17-18 June, 2004, Uppsala, Sweden. (http://www.page-meeting.org/)
  • Sparacino G, Maran A, Pavanini A, Corazza S, Crepaldi C, Avogaro A, Cobelli C. On-line glucose prediction from continuous monitoring subcutaneous sensor, In: Proceedings of the X MEDICON Mediterranean Conference on Medical and Biological Engineering, Naples, 31 July - 5 August, 2004.
  • Telford DE, Lipson SM, Barrett PHR, Sutherland BG, Aebi JD, Morand OH, Huff MW. A novel inhibitor of oxidosqualene cyclase decreases VLDL and LDL apoB100 through decreased VLDL production and enhanced LDL catabolism. XV International Symposium on Drugs affecting Lipid Metabolism Meeting, Venice, October 2004. (http://www.lorenzinifoundation.org/dalm2004/pag1-20.pdf)
  • Toffolo G, Dalla Man C, Basu R, Rizza R, Cobelli C. Assessment of postprandial glucose metabolism: conventional vs triple tracer method. Diabetologia 47, Suppl.1, A590, 2004.
  • Vicini P. Model-based biomarkers. AAPS Workshop on Clinical Biomarkers in Drug Development: Efficacy Assessment, Pharmacokinetics/Pharmacodynamics and Regulatory Insights, November 5 - 6, 2004, Holiday Inn Inner Harbour, Baltimore, MD. (http://www.aapspharmaceutica.com/meetings/meeting.asp?id=38)
  • Vicini P. Designing Model-Based Probes: Accomplishments and Challenges in Understanding Glucose Homeostasis. Proceedings of PKUK 2004, 17th - 19th November 2004, Belfast, Northern Ireland, UK, p. 5-6.
  • Watts GF, Farvid MS, Zilko SR, Allen MC, Chan DC, Barrett PHR. Kinetic determinants of plasma HDL apoA-I concentration in normolipidemic healthy subjects: Analysis of stable and radioactive isotope studies. Atherosclerosis Suppl 2004; 5: 66.
  • Whitfield AJ, Crawford G, Barrett PH, Robertson K, Hegele RA, Tran K, Yao ZM, van Bockxmeer FM, Burnett JR. A novel nontruncating APOB gene mutation, L343V, causes familial hypobetalipoproteinemia. Arteriosclerosis Thrombosis and Vascular Biology 24 (5): E55 P314 May 2004
  • Whitfield AJ, Crawford G, Barrett PHR, Robertson K, Hegele RA, Tran K, Yao Z, van Bockxmeer FM, Burnett JR. A novel non-truncating APOB gene mutation, L343V, causes familial hypobetalipoproteinaemia. Atherosclerosis Suppl 2004; 5: 78.
  • Whitfield AJ, Barrett PHR, Robertson K, van Bockxmeer FM, Burnett JR. Liver dysfunction in a man with HFE C282Y/H63D, a1-antitrypsin PiZ, and familial hypobetalipoproteinaemia. Atherosclerosis Suppl 2004; 5: 158.
  • Whitfield AJ, Crawford G, Barrett PHR, Robertson K, Hegele RA, Tran K, Yao Z, van Bockxmeer FM, Burnett JR. A Novel Nontruncating APOB Gene Mutation, L343V, Causes Familial Hypobetalipoproteinemia. Arterio Thromb Vasc Biol 2004; 24: e105.
  • Zanderigo F, Bertoldo A, Pillonetto G, Cosottini M, Cobelli C. Nonlinear stochastic regularization to characterize tissue residue function from bolus-tracking MRI images. ISMRM Workshop on Quantitative Cerebral Perfusion Imaging using MRI: A Technical Perspective 21-23 March 2004, San Servolo, Venice, Italy.
  • Zierhut ML, Peterson MC, Gastonguay MR, Martin SW, Vicini P, Bekker PJ, Holloway D, Leese PT. Development and Evaluation of a Population PK/PD Model for Fc-OPG in Healthy Postmenopausal Women. PAGE (Population Approach Group in Europe) Thirteenth Meeting, 17-18 June, 2004, Uppsala, Sweden. (http://www.page-meeting.org/)
   
[top of page]

main : what's new : R&D : service : collaboration : team RFPK
publications : training : about RFPK : contact RFPK : members only
search

 

copyright © 2000-2007 Resource Facility for Population Kinetics